bioAffinity Technologies Net Profit Margin Growth & History (BIAF)
bioAffinity Technologies's net profit margin was −241.96% for fiscal 2025.
View full bioAffinity Technologies company overviewbioAffinity Technologies annual net profit margin history
| Fiscal year | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −241.96% | −145.41 pp |
| 2024 | 2024-12-31 | −96.56% | +216.85 pp |
| 2023 | 2023-12-31 | −313.41% | +169457.84 pp |
| 2022 | 2022-12-31 | −169,771.25% | — |
bioAffinity Technologies quarterly net profit margin
| Fiscal quarter | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −222.83% | +97.04 pp |
| Q1 2026 | 2026-03-31 | −268.63% | −125.10 pp |
| Q4 2025 | 2025-12-31 | −196.98% | −62.58 pp |
| Q3 2025 | 2025-09-30 | −349.30% | −264.17 pp |
| Q2 2025 | 2025-06-30 | −319.88% | −231.86 pp |
| Q1 2025 | 2025-03-31 | −143.53% | −62.00 pp |
| Q4 2024 | 2024-12-31 | −134.40% | −27.17 pp |
| Q3 2024 | 2024-09-30 | −85.13% | +682.38 pp |
| Q2 2024 | 2024-06-30 | −88.01% | +8728.34 pp |
| Q1 2024 | 2024-03-31 | −81.53% | +166345.18 pp |
| Q4 2023 | 2023-12-31 | −107.22% | — |
| Q3 2023 | 2023-09-30 | −767.51% | +427011.45 pp |
| Q2 2023 | 2023-06-30 | −8,816.36% | −2074.25 pp |
| Q1 2023 | 2023-03-31 | −166,426.71% | — |
| Q3 2022 | 2022-09-30 | −427,778.96% | — |
| Q2 2022 | 2022-06-30 | −6,742.11% | — |
bioAffinity Technologies net profit margin trends
Between the periods ended 2022-12-31 and 2025-12-31, bioAffinity Technologies's net profit margin increased from −169,771.25% to −241.96%, a change of +169529.28 percentage points. The latest reported quarter, Q2 2026, shows −222.83%.
What net profit margin means
Net profit margin measures the percentage of revenue remaining as net income after operating costs, interest, taxes, and other expenses. It shows how much bottom-line profit or loss a company generates from each dollar of revenue.
How net profit margin is calculated
TickerStat calculates net profit margin as SEC-reported net income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review bioAffinity Technologies source filings ↗